Loading quotes...

Forecast

The analysts' average price target is €99.92 (+21.97%). The median is €100.59 (+22.79%).

Buy	35
Hold	6
Sell	0

News Go to news feed

CVS Health praised for GLP-1 program after strong healthcare showing in Q2 investor letter

Polaris Global Equity Strategy highlighted CVS Health's June 2026 launch of a comprehensive GLP-1 program combining lower-cost access, pharmacist support and tailored OTC products, saying investors welcomed the strategy to capture share of the weight-loss market. The firm noted the Composite outperformed in health care with multiple holdings posting double-digit gains and reported CVS shares at $87.10 with a market cap of $111.4 billion as of September 22, 2026. » More on finance.yahoo.com
CVS outlines turnaround: debt reduction, AI use and return to margins in focus

At the Wells Fargo Healthcare Conference, CVS presented a comprehensive turnaround strategy that includes tighter pricing, operational optimization and increased use of technology. Leverage fell from 5x in 2024 to the mid-3x range after $4 billion of debt paydown, with the BBB rating maintained. The Pharmacy & Consumer Wellness division is growing again in the mid-single digits, Caremark remains under pressure and the 340B program will weigh on 2025–2026; stabilization is expected by the end of 2026. CVS cites AI and digital projects as drivers of more than $1 billion in productivity gains, plans possible buybacks for 2026 and is relying on Oak Street Health to improve the portfolio over the long term. » More on de.investing.com
CVS Health outperforms in 2026 as analysts see about 22% upside

CVS Health has climbed over 18% year-to-date after three consecutive quarters of revenue and profit beats and repeated guidance raises. Stronger performance in its healthcare benefits segment, led by Aetna and a sharply lower medical benefit ratio, drove substantial increases in adjusted operating income. Analyst consensus price target sits at $114.59 (roughly 22% above the recent close) with most analysts rating the stock a buy, despite operational challenges at Caremark. Investors are pricing continued benefit-segment strength amid an aging U.S. population as the main growth driver. » More on finance.yahoo.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, CVS Health has already paid €1.71 in dividends. The last payout was in August.

Financials

In the last quarter, CVS Health had revenue of €92.96B and net profit of €2.62B

(EUR)	June 2026	YoY
Revenue	92.96B	10.77%
Gross profit	13.8B	19.66%
Net profit	2.62B	202.95%
EBITDA	5.13B	69.00%

Fundamentals

Metric	Value
Market capitalization	€107.37B
Number of shares	1.28B
52-week high/low	€99.41 - €62.43
Dividend yield	2.77%
Dividends TTM	€2.29
Next dividend	€0.60
Beta	0.60
P/E ratio	24.40
PEG ratio	3.82
P/B ratio	1.50
P/S ratio	0.29

Company profile

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Name	CVS Health
CEO	J. David Joyner
Headquarters	Woonsocket, ri USA
Website	cvshealth.com
Sector	Health Care
Industry	Health Care Providers & Services
IPO	02/21/1973
Employees	259,500